Stock Information
Candel Therapeutics Inc (CADL)
Ticker Symbol: CADL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $706.33 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -0.9776
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -60.42%
Latest News
-
Stifel Initiates Coverage On Candel Therapeutics with Buy Rating, Announces Price Target of $22
Mon, Jul 13, 2026 5:53 AM
Key Financials
Financial data not available
